T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment
about
Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis casesCorrelation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis.Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workersRole of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection.Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected childrenIFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapyProfiling B and T cell immune responses to co-infection of Mycobacterium tuberculosis and hookworm in humansMonocyte signal transduction receptors in active and latent tuberculosisInterferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the EvidenceBronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study.T-SPOT.TB assay usage in adults and children.25(OH)D(3) affects the maturation and function of mouse bone marrow-derived dendritic cells stimulated by Mycobacterium bovis BCG.Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis.Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease.Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatmentSpecific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapyIFN-γ-release assays to diagnose TB infection in the immunocompromised individual
P2860
Q28475371-CC297BB3-FBAB-40AF-BA82-BF5831C7394AQ30391651-50727EE1-C0A4-47F9-BE9A-8C91F6F76A25Q30979334-D7DC2C0A-7C5D-4B20-9527-3BB652CDDD57Q33496134-CC7D9ABD-4188-4ABB-BCA9-80A00DD75C69Q33543398-07ACFDB5-8E70-4C4D-8F5B-1A7E138C7023Q33589272-FB4F7764-946E-4221-A43F-40F60BB4BCD0Q33767082-00649F85-BC3F-47F0-A669-B4BF3043E5BCQ33905874-1FF0973B-C89C-483C-9FDB-798CA928319DQ35580234-66D5B049-CCCC-4E47-9692-0C605106CE45Q36582615-7F7F65A7-B9EC-40CB-B330-D7E71E2BA4D1Q36637982-A879FA3A-A428-4E29-B78A-8785695797C9Q37366903-582B79BB-A0AD-45B0-9E16-10E1651D801BQ37899891-53D5DC7B-0E65-42CB-86CB-A470D8A9AFD7Q41471112-641ABE4B-1BA6-4AE6-AA7A-202AC1529A98Q45159611-225FEFEA-9F37-4864-B501-5F6318253570Q51771302-3D9E466D-EB5C-4D79-A9D5-02FDF472F972Q58924832-C4432A88-3001-4AAB-87F2-C9260FCE28B8Q58924838-9863FC89-3A89-49F7-97C3-24F87EBD6716Q58924849-D522783A-86D9-416F-BA1D-8CD4BBC4B97D
P2860
T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2009
@uk
name
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@en
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@nl
type
label
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@en
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@nl
prefLabel
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@en
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@nl
P2093
P50
P921
P1476
T-cell responses to the Mycoba ...... ter antituberculosis treatment
@en
P2093
Celia Milà
Cristina Prat
José Maldonado
Juan Ruiz-Manzano
Maria Angeles Jiménez
Neus Altet
Silvia Blanco
P356
10.1016/J.DIAGMICROBIO.2008.09.010
P577
2008-11-21T00:00:00Z